Biochemical Engineering Special Interest Group
biological engineering professionals
16 February 2016

Lonza Biologics Expansion Could Mean 400 New Jobs

Planned capital projects totaling more than $200 million at the Portsmouth facilities of Swiss-based Lonza Biologics (LONN.VX) could result in the company adding on more than 400 new jobs.  In a letter to Portsmouth officials, Michael Pelletier, Lonza’s site manager, said the planned expansion could reach up to $300 million in “growth investment.”. In addition to manufacturing clinical therapies for other companies, Lonza announced in February that it was planning to offer its customers a “complete portfolio of development and manufacturing services for clinical outsourcing requirements by entering into Drug Product Services. Source: Biospace 16/2/2016

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).